{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T11:44:59Z","timestamp":1768823099635,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008897","name":"Nihon Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Therapy"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.reth.2019.08.005","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T05:33:48Z","timestamp":1568957628000},"page":"269-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Mesenchymal stem cells cultured under hypoxic conditions had a greater therapeutic effect on mice with liver cirrhosis compared to those cultured under normal oxygen conditions"],"prefix":"10.1016","volume":"11","author":[{"given":"Yuichi","family":"Kojima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsunori","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Nojiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Kikuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Takamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Terai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reth.2019.08.005_bib1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41575-018-0045-2","article-title":"Novel perspectives in the management of decompensated cirrhosis","volume":"15","author":"Bernardi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.reth.2019.08.005_bib2","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","article-title":"Sofosbuvir and velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 infection","volume":"373","author":"Feld","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.reth.2019.08.005_bib3","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1056\/NEJMoa1512614","article-title":"Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis","volume":"373","author":"Curry","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.reth.2019.08.005_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/gast.2003.50013","article-title":"Histological outcome during long-term lamivudine therapy","volume":"124","author":"Dienstag","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.reth.2019.08.005_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00535-016-1258-1","article-title":"Status of and candidates for cell therapy in liver cirrhosis: overcoming the \u201cpoint of no return\u201d in advanced liver cirrhosis","volume":"52","author":"Terai","year":"2017","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.reth.2019.08.005_bib6","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/hep.24434","article-title":"Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes","volume":"54","author":"Peng","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.reth.2019.08.005_bib7","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/hep.28693","article-title":"Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: phase 2 trial","volume":"64","author":"Suk","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.reth.2019.08.005_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/sctm.18-0105","article-title":"Mesenchymal stem cells and induced bone marrow-derived macrophages synergistically improve liver fibrosis in mice","volume":"8","author":"Watanabe","year":"2019","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.reth.2019.08.005_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s41232-017-0045-6","article-title":"Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases","volume":"37","author":"Tsuchiya","year":"2017","journal-title":"Inflamm Regen"},{"key":"10.1016\/j.reth.2019.08.005_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13287-017-0730-z","article-title":"Preconditioning of murine mesenchymal stem cells synergistically enhanced immunomodulation and osteogenesis","volume":"8","author":"Lin","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.reth.2019.08.005_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/cbf.3338","article-title":"Anti-apoptotic effects of adipose-derived adherent stromal cells in mesenchymal stem cells exposed to oxidative stress","volume":"36","author":"Shin","year":"2018","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.reth.2019.08.005_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1549-8719.2011.00154.x","article-title":"miR-210: the master hypoxamir","volume":"19","author":"Chan","year":"2012","journal-title":"Microcirculation"},{"key":"10.1016\/j.reth.2019.08.005_bib13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s13287-018-1039-2","article-title":"Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization","volume":"9","author":"Philipp","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.reth.2019.08.005_bib14","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/stem.2643","article-title":"Human adipose-derived mesenchymal stem cell-secreted CXCL1 and CXCL8 facilitate breast tumor growth by promoting angiogenesis","volume":"35","author":"Wang","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.reth.2019.08.005_bib15","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/stem.2612","article-title":"High aldehyde dehydrogenase activity identifies a subset of human mesenchymal stromal cells with vascular regenerative potential","volume":"35","author":"Sherman","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.reth.2019.08.005_bib16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12967-018-1601-9","article-title":"Comparing atmospheric and hypoxic cultured mesenchymal stem cell transcriptome: implication for stem cell therapies targeting intervertebral discs","volume":"16","author":"Elabd","year":"2018","journal-title":"J\u00a0Transl Med"},{"issue":"Pt A","key":"10.1016\/j.reth.2019.08.005_bib17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.mito.2014.07.005","article-title":"Mesenchymal stem cells and hypoxia: where are we?","volume":"19","author":"Buravkova","year":"2014","journal-title":"Mitochondrion"},{"key":"10.1016\/j.reth.2019.08.005_bib18","first-page":"9283432","article-title":"Mathematical modeling reveals the role of hypoxia in the promotion of human mesenchymal stem cell long-term expansion","volume":"2018","author":"Gao","year":"2018","journal-title":"Stem Cell Int"},{"key":"10.1016\/j.reth.2019.08.005_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/scrt153","article-title":"High targeted migration of human mesenchymal stem cells grown in hypoxia is associated with enhanced activation of RhoA","volume":"4","author":"Vertelov","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.reth.2019.08.005_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12309","article-title":"Hypoxia and low-dose inflammatory stimulus synergistically enhance bone marrow mesenchymal stem cell migration","volume":"50","author":"Yu","year":"2017","journal-title":"Cell Prolif"},{"key":"10.1016\/j.reth.2019.08.005_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/scrt234","article-title":"Hypoxia preconditioned bone marrow mesenchymal stem cells promote liver regeneration in a rat massive hepatectomy model","volume":"4","author":"Yu","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.reth.2019.08.005_bib22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13287-018-0902-5","article-title":"Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34+ cells","volume":"9","author":"Zhao","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.reth.2019.08.005_bib23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.biomaterials.2018.03.027","article-title":"The influence of hypoxia and IFN-gamma on the proteome and metabolome of therapeutic mesenchymal stem cells","volume":"167","author":"Wobma","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.reth.2019.08.005_bib24","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/stem.2853","article-title":"Hypoxic preconditioning of mesenchymal stem cells with subsequent spheroid formation accelerates repair of segmental bone defects","volume":"36","author":"Ho","year":"2018","journal-title":"Stem Cells"},{"key":"10.1016\/j.reth.2019.08.005_bib25","doi-asserted-by":"crossref","first-page":"816","DOI":"10.5966\/sctm.2015-0191","article-title":"Hypoxic conditioned medium from human adipose-derived stem cells promotes mouse liver regeneration through JAK\/STAT3 signaling","volume":"5","author":"Lee","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.reth.2019.08.005_bib26","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/stem.2618","article-title":"Hypoxia inducible factor-1alpha potentiates jagged 1-mediated angiogenesis by mesenchymal stem cell-derived exosomes","volume":"35","author":"Gonzalez-King","year":"2017","journal-title":"Stem Cells"}],"container-title":["Regenerative Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320419300811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320419300811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:39:32Z","timestamp":1762450772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352320419300811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":26,"alternative-id":["S2352320419300811"],"URL":"https:\/\/doi.org\/10.1016\/j.reth.2019.08.005","relation":{},"ISSN":["2352-3204"],"issn-type":[{"value":"2352-3204","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stem cells cultured under hypoxic conditions had a greater therapeutic effect on mice with liver cirrhosis compared to those cultured under normal oxygen conditions","name":"articletitle","label":"Article Title"},{"value":"Regenerative Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reth.2019.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}